{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T01:22:31Z","timestamp":1744593751262,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070384"],"award-info":[{"award-number":["82070384"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011668"],"award-info":[{"award-number":["2021A1515011668"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03728-0","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:06:18Z","timestamp":1718967978000},"page":"1213-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac autonomic neuropathy modified the association between obesity and hypoglycemia in type 2 diabetes"],"prefix":"10.1007","volume":"85","author":[{"given":"Wenjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxue","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"10365","key":"3728_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"E. Ahmad, S. Lim, R. Lamptey, D.R. Webb, M.J. Davies, Type 2 diabetes. Lancet 400(10365), 1803\u20131820 (2022)","journal-title":"Lancet"},{"issue":"12","key":"3728_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1056\/NEJMoa2200433","volume":"387","author":"GSR Group","year":"2022","unstructured":"G.S.R. Group, D.M. Nathan, J.M. Lachin, A. Balasubramanyam, H.B. Burch, J.B. Buse et al. Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes. N. Engl. J. Med. 387(12), 1063\u20131074 (2022)","journal-title":"N. Engl. J. Med."},{"key":"3728_CR3","doi-asserted-by":"publisher","first-page":"b4909","DOI":"10.1136\/bmj.b4909","volume":"340","author":"DE Bonds","year":"2010","unstructured":"D.E. Bonds, M.E. Miller, R.M. Bergenstal, J.B. Buse, R.P. Byington, J.A. Cutler et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340, b4909 (2010)","journal-title":"BMJ"},{"issue":"12A","key":"3728_CR4","doi-asserted-by":"publisher","first-page":"80i","DOI":"10.1016\/j.amjcard.2007.03.026","volume":"99","author":"DE Bonds","year":"2007","unstructured":"D.E. Bonds, E.M. Kurashige, R. Bergenstal, D. Brillon, M. Domanski, J.V. Felicetta et al. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am. J. Cardiol. 99(12A), 80i\u201389ii (2007)","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"3728_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4093\/dmj.2016.40.6.423","volume":"40","author":"JS Yun","year":"2016","unstructured":"J.S. Yun, S.H. Ko, Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus. Diabetes Metab. J. 40(6), 423\u2013432 (2016)","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"3728_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.diabet.2018.03.006","volume":"45","author":"JS Yun","year":"2019","unstructured":"J.S. Yun, Y.M. Park, K. Han, S.A. Cha, Y.B. Ahn, S.H. Ko, Association between BMI and risk of severe hypoglycaemia in type 2 diabetes. Diabetes Metab. 45(1), 19\u201325 (2019)","journal-title":"Diabetes Metab."},{"issue":"1","key":"3728_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jama.289.1.76","volume":"289","author":"AH Mokdad","year":"2003","unstructured":"A.H. Mokdad, E.S. Ford, B.A. Bowman et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289(1), 76\u201379 (2003)","journal-title":"JAMA"},{"issue":"1","key":"3728_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02596-7","volume":"20","author":"K Jayanama","year":"2022","unstructured":"K. Jayanama, O. Theou, J. Godin, A. Mayo, L. Cahill, K. Rockwood, Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults. BMC Med. 20(1), 404 (2022)","journal-title":"BMC Med."},{"issue":"21","key":"3728_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"C.J. Lavie, R.V. Milani, H.O. Ventura, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53(21), 1925\u20131932 (2009)","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"3728_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03795-z","volume":"25","author":"D Plecko","year":"2021","unstructured":"D. Plecko, N. Bennett, J. Martensson, R. Bellomo, The obesity paradox and hypoglycemia in critically ill patients. Crit. Care 25(1), 378 (2021)","journal-title":"Crit. Care"},{"key":"3728_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/DMSO.S129797","volume":"10","author":"VL Fisher","year":"2017","unstructured":"V.L. Fisher, A.A. Tahrani, Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes Metab. Syndr. Obes. 10, 419\u2013434 (2017)","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"6","key":"3728_CR12","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s13300-019-00693-0","volume":"10","author":"SM Williams","year":"2019","unstructured":"S.M. Williams, A. Eleftheriadou, U. Alam, D.J. Cuthbertson, J.P.H. Wilding, Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review. Diabetes Ther. 10(6), 1995\u20132021 (2019)","journal-title":"Diabetes Ther."},{"issue":"10","key":"3728_CR13","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.clinthera.2022.09.002","volume":"44","author":"S Williams","year":"2022","unstructured":"S. Williams, S.A. Raheim, M.I. Khan, U. Rubab, P. Kanagala, S.S. Zhao et al. Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management. Clin. Ther. 44(10), 1394\u20131416 (2022)","journal-title":"Clin. Ther."},{"issue":"22","key":"3728_CR14","doi-asserted-by":"publisher","first-page":"e156334","DOI":"10.1172\/jci.insight.156334","volume":"7","author":"AD Kaze","year":"2022","unstructured":"A.D. Kaze, M.F. Yuyun, R.S. Ahima, M.R. Rickels, J.B. Echouffo-Tcheugui, Autonomic dysfunction and risk of severe hypoglycemia among individuals with type 2 diabetes. JCI Insight 7(22), e156334 (2022)","journal-title":"JCI Insight"},{"issue":"12A","key":"3728_CR15","first-page":"21i","volume":"99","author":"AS Group","year":"2007","unstructured":"A.S. Group, J.B. Buse, J.T. Bigger, R.P. Byington, L.S. Cooper, W.C. Cushman et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am. J. Cardiol. 99(12A), 21i\u201333i (2007)","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"3728_CR16","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.2337\/dc09-0125","volume":"32","author":"AR Cobitz","year":"2009","unstructured":"A.R. Cobitz, P. Ambery, Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care 32(5), e58 (2009)","journal-title":"Diabetes Care"},{"issue":"4","key":"3728_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ejhf.2432","volume":"24","author":"AD Kaze","year":"2022","unstructured":"A.D. Kaze, M.F. Yuyun, S. Erqou, G.C. Fonarow, J.B. Echouffo-Tcheugui, Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes. Eur. J. Heart Fail 24(4), 634\u2013641 (2022)","journal-title":"Eur. J. Heart Fail"},{"issue":"9","key":"3728_CR18","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.2337\/dc14-0445","volume":"37","author":"M Jaiswal","year":"2014","unstructured":"M. Jaiswal, K. McKeon, N. Comment, J. Henderson, S. Swanson, C. Plunkett et al. Association Between Impaired Cardiovascular Autonomic Function and Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care 37(9), 2616\u20132621 (2014)","journal-title":"Diabetes Care"},{"issue":"11","key":"3728_CR19","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2337\/diacare.21.11.1960","volume":"21","author":"C Meyer","year":"1998","unstructured":"C. Meyer, R. Grossmann, A. Mitrakou et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 21(11), 1960\u20131966 (1998)","journal-title":"Diabetes Care"},{"issue":"6","key":"3728_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/diabetes.53.6.1535","volume":"53","author":"SP Lee","year":"2004","unstructured":"S.P. Lee, L. Yeoh, N.D. Harris et al. Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes. Diabetes 53(6), 1535\u20131542 (2004)","journal-title":"Diabetes"},{"issue":"1","key":"3728_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2337\/dc13-1164","volume":"37","author":"JS Yun","year":"2014","unstructured":"J.S. Yun, J.H. Kim, K.H. Song, Y.B. Ahn, K.H. Yoon, K.D. Yoo et al. Cardiovascular autonomic dysfunction predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care 37(1), 235\u2013241 (2014)","journal-title":"Diabetes Care"},{"issue":"1","key":"3728_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/dc20-1842","volume":"44","author":"Y Tang","year":"2021","unstructured":"Y. Tang, H. Shah, C.R. Bueno Junior, X. Sun, J. Mitri, M. Sambataro et al. Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial. Diabetes Care 44(1), 164\u2013173 (2021)","journal-title":"Diabetes Care"},{"issue":"7","key":"3728_CR23","doi-asserted-by":"publisher","first-page":"e2743","DOI":"10.1210\/clinem\/dgac195","volume":"107","author":"AD Kaze","year":"2022","unstructured":"A.D. Kaze, M.F. Yuyun, S. Erqou, G.C. Fonarow, J.B. Echouffo-Tcheugui, Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults With Type 2 Diabetes. J. Clin. Endocrinol. Metab. 107(7), e2743\u2013e2750 (2022)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3728_CR24","doi-asserted-by":"publisher","first-page":"b5444","DOI":"10.1136\/bmj.b5444","volume":"340","author":"ME Miller","year":"2010","unstructured":"M.E. Miller, D.E. Bonds, H.C. Gerstein, E.R. Seaquist, R.M. Bergenstal, J. Calles-Escandon et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340, b5444 (2010)","journal-title":"BMJ"},{"issue":"15","key":"3728_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","volume":"363","author":"S Zoungas","year":"2010","unstructured":"S. Zoungas, A. Patel, J. Chalmers et al. Severe hypoglycemia and risks of vascular events and death. N. Engl. J. Med 363(15), 1410\u20131418 (2010)","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"3728_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","volume":"61","author":"TB Horwich","year":"2018","unstructured":"T.B. Horwich, G.C. Fonarow, A.L. Clark, Obesity and the Obesity Paradox in Heart Failure. Prog. Cardiovasc Dis. 61(2), 151\u2013156 (2018)","journal-title":"Prog. Cardiovasc Dis."},{"issue":"Suppl 2","key":"3728_CR27","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dcS13-2023","volume":"36","author":"V Hainer","year":"2013","unstructured":"V. Hainer, I. Aldhoon-Hainerova, Obesity paradox does exist. Diabetes Care 36(Suppl 2), S276\u2013S281 (2013)","journal-title":"Diabetes Care"},{"issue":"4","key":"3728_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccc.2010.06.004","volume":"26","author":"DE Amundson","year":"2010","unstructured":"D.E. Amundson, S. Djurkovic, G.N. Matwiyoff, The obesity paradox. Crit. Care Clin. 26(4), 583\u2013596 (2010)","journal-title":"Crit. Care Clin."},{"issue":"4","key":"3728_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.2337\/dc13-2507","volume":"37","author":"AP Kong","year":"2014","unstructured":"A.P. Kong, X. Yang, A. Luk et al. Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry. Diabetes Care 37(4), 1024\u20131031 (2014)","journal-title":"Diabetes Care"},{"issue":"7","key":"3728_CR30","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1210\/jc.2004-1963","volume":"90","author":"L Perego","year":"2005","unstructured":"L. Perego, P. Pizzocri, D. Corradi, F. Maisano, M. Paganelli, P. Fiorina et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J. Clin. Endocrinol. Metab. 90(7), 4087\u20134093 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3728_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02559-7","volume":"18","author":"YR Lai","year":"2020","unstructured":"Y.R. Lai, M.H. Chen, W.C. Lin, W.C. Chiu, B.C. Cheng, J.F. Chen et al. Leptin mediate central obesity on the severity of cardiovascular autonomic neuropathy in well-controlled type 2 diabetes and prediabetes. J. Transl. Med. 18(1), 396 (2020)","journal-title":"J. Transl. Med."},{"key":"3728_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12933-015-0280-6","volume":"14","author":"M Kurajoh","year":"2015","unstructured":"M. Kurajoh, H. Koyama, M. Kadoya, M. Naka, A. Miyoshi, A. Kanzaki et al. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol. 14, 117 (2015)","journal-title":"Cardiovasc Diabetol."},{"issue":"3","key":"3728_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","volume":"115","author":"AI Vinik","year":"2007","unstructured":"A.I. Vinik, D. Ziegler, Diabetic cardiovascular autonomic neuropathy. Circulation 115(3), 387\u2013397 (2007)","journal-title":"Circulation"},{"key":"3728_CR34","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.phrs.2021.105782","volume":"171","author":"E Lazzaroni","year":"2021","unstructured":"E. Lazzaroni, M. Ben Nasr, C. Loretelli, I. Pastore, L. Plebani, M.E. Lunati et al. Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharm. Res. 171, 105782 (2021)","journal-title":"Pharm. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03728-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T06:21:59Z","timestamp":1723270919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03728-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3728"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03728-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"12 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}